Intas Pharmaceuticals Limited Ezetimibe Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Ezetimibe Export Records India — #3 Exporter, 333 Shipments, $16.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Ezetimibe

India Pharmaceutical Trade Intelligence

$514.5M169 Suppliers85 CountriesHS 30049099

ExportsIndia → UNITED STATES44.9%India → GERMANY41.4%

ImportsMALTA → India$3.0M GERMANY → India$37.8K

#1 Supplier: PIRAMAL PHARMA

Intas Pharmaceuticals Limited — Ezetimibe Exporter #3 | $16.6M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Ezetimibe Exporter Profile

Indian Pharmaceutical Exporter · #3 for Ezetimibe · $16.6M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #3 Indian exporter of Ezetimibe with $16.6M in export value and 333 verified shipments. Intas Pharmaceuticals Limited holds a 3.2% market share in Ezetimibe exports across 17 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Ezetimibe Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Ezetimibe export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Ezetimibe?

Country	Value	Shipments	Share
AUSTRALIA	$2.3M	83	32.2%
GERMANY	$1.0M	23	14.4%
HONG KONG	$894.6K	24	12.4%
NETHERLANDS	$647.8K	45	9.0%

Who Are the Top Buyers of Ezetimibe from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
TO THE ORDER	HONG KONG	$842.9K	38
APOTEX PTY LTD	AUSTRALIA	$578.6K	30
STANDARD CHARTERED BANK (HK) LTD.	HONG KONG	$542.3K	15
NEXTPHARMA LOGISTIC GMBH	GERMANY	$539.7K	12
TO THE ORDER.,	GERMANY	$530.5K	16
ARROW PHARMACEUTICALS PTY LTD	AUSTRALIA	$446.1K	14
ACCORD HEALTHCARE PTE LTD	SINGAPORE	$403.0K	30
BROCACEF NL : HUB	NETHERLANDS	$366.6K	21
APOTEX PTY LIMITED	AUSTRALIA	$356.5K	10
ACCORD HEALTHCARE SDN BHD	MALAYSIA	$326.2K	12

Intas Pharmaceuticals Limited supplies Ezetimibe to 41 buyers globally. The largest buyer is TO THE ORDER (HONG KONG), followed by APOTEX PTY LTD (AUSTRALIA) and STANDARD CHARTERED BANK (HK) LTD. (HONG KONG). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Ezetimibe Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUGS & MEDI EZETIMIBE 10MG 7X14T	$345.4K	14
PHARMA DRUGS & MEDI EZETIMIBE TABLET USP	$240.1K	7
PHARMACEUTICAL DRUGS AND MEDICINE - EZETIMIBE 10 MG - AS PER INVOICE	$237.2K	5
PHARMA DRUGS AND MEDI ACCORD EZETIMIBE 1	$200.0K	4
PHARMA DRUGS AND MEDI LIPEZ EZETIMIBE 10MG 3X10T AS PER INV	$178.9K	12
PHR DRUGS MEDI EZEMICHOL EZE 10MG 3X10T ARROTEX AUS EACH UNCOATED TABLET CONTAINSEZETIMIBE USP 10MG	$161.7K	5
EZETIMIB EZE. 10MG EACH TABLET CONTAINSEZETIMIBE 10 MG DETAILS AS PER INVOICE	$155.4K	4
PHAR.DRUGS AND MED.: KOBEY EZETIMIB10MGEACH UNCOATED TABLET CONTAINS: EZETIMIBE10 MG EXCIPIENTS: Q.S. NET WT. 1149.840	$150.0K	3
PHARM DRUG&MED EZETIMIBE-WGR 10MG 3X10T(WAGNER-AUS) EACH UNCOATED TABLET CONTAINSEZETIMIBE USP...............10MG	$150.0K	3
PHARMA DRUGS AND MEDI LIPEZ EZETIMIBE 10MG 3X10T(ACC-SIN) EACH UNCOATED TABLET CONTAINS: EZETIMIBE 10 MG	$140.8K	14

Intas Pharmaceuticals Limited exports 138 distinct Ezetimibe formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS & MEDI EZETIMIBE 10MG 7X14T with 14 shipments worth $345.4K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Ezetimibe Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	ALKEM LABORATORIES LIMITED	$19.4M	389	5	$50.0K
3	INTAS PHARMACEUTICALS LIMITED ★	$16.6M	333	17	$50.0K
1	PIRAMAL PHARMA LIMITED	$13.4M	269	3	$50.0K
5	MEDREICH LIMITED	$12.4M	406	9	$30.5K

Intas Pharmaceuticals Limited ranks #3 among 169 Indian Ezetimibe exporters. Average shipment value of $50.0K compared to the market average of $628.6K. The closest competitors by value are ALKEM LABORATORIES LIMITED and PIRAMAL PHARMA LIMITED.

Which Indian Ports Ship Ezetimibe Exports?

Port	Shipments	% Share
SAHAR AIR	814	16.2%
SAHAR AIR CARGO ACC (INBOM4)	663	13.2%
DELHI AIR CARGO ACC (INDEL4)	515	10.2%
DELHI AIR	369	7.3%
NHAVA SHEVA SEA (INNSA1)	235	4.7%
Bombay Air	164	3.3%
BANGALORE AIR	152	3.0%
MUNDRA SEA	150	3.0%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Ezetimibe Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Ezetimibe shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 343 individual customs records matching Intas Pharmaceuticals Limited exporting Ezetimibe, covering 138 formulations to 17 countries via 41 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 85+ countries, 466+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Ezetimibe

Ezetimibe

Intas Pharmaceuticals Limited — Ezetimibe Exporter Profile

Intas Pharmaceuticals Limited — Ezetimibe Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Ezetimibe?

Who Are the Top Buyers of Ezetimibe from Intas Pharmaceuticals Limited?

What Is India's Total Ezetimibe Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Ezetimibe Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Ezetimibe Exporters?

What Ezetimibe Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Ezetimibe to Key Markets

Australia — TGA

Germany — BfArM/EMA

How Does Intas Pharmaceuticals Limited Compare to Nearest Ezetimibe Exporters?

Which Indian Ports Ship Ezetimibe Exports?

Ezetimibe — Export Intelligence Video

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Ezetimibe Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Ezetimibe Export Data from Intas Pharmaceuticals Limited

Ezetimibe Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source